You are here

Takeda

J&J's Ethicon Spends $400M for Takeda’s Fibrin Sealant Patch

Medical Devices and Diagnostics Industry

Sat, 05/11/19 - 12:17 pm

Fibrin Sealant Patch

Takeda sells Shire’s Xiidra, transfers 400 staffers to Novartis in $3.4B deal

Fierce Pharma

Thu, 05/9/19 - 11:11 am

dry eye disease

Novartis Considers Offer for Takeda Eye-Disease Assets

Bloomberg

Wed, 05/8/19 - 05:25 pm

Takeda’s Entyvio Ad Captures Struggle to Make Plans

Xtalks

Mon, 05/6/19 - 10:52 am

inflammatory bowel disease

Takeda Unites San Diego Operations At New ‘Biotech-Style’ R&D Center

Xconomy

Tue, 04/30/19 - 09:41 am

Big Pharma come together for better drug side effect detection

Pharma Times

Sun, 04/7/19 - 05:18 pm

Bristol-Myers Squibb

Gilead Sciences

International Working Group on Signal Detection and Management in Pharmacovigilance

pharmacovigilance

Takeda takes a cautious step into neurological gene therapy, inking preclinical deal with StrideBio

Endpoints

Sat, 03/30/19 - 12:10 am

Takeda’s Entyvio Bests Humira in Head-to-Head UC Study

BioSpace

Mon, 03/11/19 - 10:25 am

ulcerative colitis

14 Drugs Earn Billions for These Massachusetts Biotechs

BioSpace

Wed, 03/6/19 - 09:59 am

Vertex Pharmaceuticals

Ironwood Pharmaceuticals

Takeda, Microsoft rare disease partnership publishes diagnosis roadmap

Fierce Pharma

Wed, 02/27/19 - 11:52 am

FDA Warns of Increased Risk of Death With Gout Medicine Uloric

RAPS.org

Fri, 02/22/19 - 10:05 am

NICE backs Takeda’s Alunbrig in second-line lung cancer

Pharmaforum

Sat, 02/16/19 - 12:02 am

ALK-positive non-small cell lung cancer

Hurricanes, droughts, and wildfires: How biopharma is girding for climate change

Stat

Fri, 02/15/19 - 10:29 am

natural disasters

tropical diseases

Artificial Intelligence Gaining Ground in Drug Development

BioSpace

Mon, 02/11/19 - 10:00 am

machine learning

artificial intelligence

drug development

Google DeepMind

Recursion Pharmaceuticals

Takeda's Hemophilia A Drug: New Data and a $155 Million Patent Infringement Settlement

BioSpace

Wed, 02/6/19 - 11:17 am

clinical trials

Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing

BioSpace

Fri, 02/1/19 - 11:27 am

Takeda's Phase III Dengue Vaccine Results Bring Them "One Step Closer" to Stopping Tropical Disease

BioSpace

Wed, 01/30/19 - 09:46 am

tropical diseases

Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more

CP Wire

Sun, 01/27/19 - 07:09 pm

Last week in biopharma-earnings reports, drug pricing, a new GENE CEO and more

Mon, 02/4/19 - 02:45 pm

Is the Smoldering NASH Market Ready to Burst Into Flames?

BioSpace

Tue, 01/22/19 - 11:52 am

Gilead Sciences

Bristol-Myers Squibb

Intercept Pharmaceuticals

Pages